Task: Answer the multiple-choice question.
Question: Which drug exhibits a -9.319\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) CC(C)c1ccc(OCC(=O)N2CCN(C(=O)c3ccco3)CC2)cc1
b) COc1ccc(Oc2c(Cl)cnn(-c3ccccc3)c2=O)cc1
Answer: b. COc1ccc(Oc2c(Cl)cnn(-c3ccccc3)c2=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(Oc2c(Cl)cnn(-c3ccccc3)c2=O)cc1
COc1ccc(Oc2c(Cl)cnn(-c3ccccc3)c2=O)cc1
5-chloro-4-(4-methoxyphenoxy)-2-phenylpyridazin-3-one